Details for New Drug Application (NDA): 022013
✉ Email this page to a colleague
The generic ingredient in OLUX E is clobetasol propionate. There are fourteen drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
Summary for 022013
Tradename: | OLUX E |
Applicant: | Mylan |
Ingredient: | clobetasol propionate |
Patents: | 2 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 022013
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | AEROSOL, FOAM;TOPICAL | Strength | 0.05% | ||||
Approval Date: | Jan 12, 2007 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Try a Trial | Patent Expiration: | Nov 5, 2028 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | TREATMENT OF CORTICOSTEROID-RESPONSIVE DERMATOSES | ||||||||
Patent: | ⤷ Try a Trial | Patent Expiration: | Aug 31, 2025 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | TREATMENT OF CORTICOSTEROID-RESPONSIVE DERMATOSES |
Expired US Patents for NDA 022013
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Mylan | OLUX E | clobetasol propionate | AEROSOL, FOAM;TOPICAL | 022013-001 | Jan 12, 2007 | ⤷ Try a Trial | ⤷ Try a Trial |
Mylan | OLUX E | clobetasol propionate | AEROSOL, FOAM;TOPICAL | 022013-001 | Jan 12, 2007 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription